India, April 22 -- Royal Philips (PHG) announced that the U.S. FDA has granted 510(k) clearance for its Rembra platform, including Rembra CT, Rembra RT, and Areta RT system.
The newly cleared technologies are designed to expand access to faster, more precise CT imaging across frontline care and cancer treatment planning. As imaging volumes and clinical complexity continue to rise, the Rembra platform aims to help healthcare providers improve speed, efficiency, and confidence in clinical decisions.
Rembra CT features the largest-in-class 85 cm bore, enabling ultra-fast, high-throughput imaging in demanding environments such as emergency departments and critical care. The system supports up to 270 exams per day, combining advanced acquisiti...